CA2014633C — Stable anhydrous compositions for topical delivery of active materials
Assigned to Helene Curtis Inc · Expires 2000-07-18 · 26y expired
What this patent protects
An anhydrous, topically-effective composition that resists phase separation and exhibits improved sensory properties comprising a topically-active compound, such as an astringent salt; a finely-divided silica; a suspending wax composition; and a suitable volatile liquid carrier v…
USPTO Abstract
An anhydrous, topically-effective composition that resists phase separation and exhibits improved sensory properties comprising a topically-active compound, such as an astringent salt; a finely-divided silica; a suspending wax composition; and a suitable volatile liquid carrier vehicle, such as a volatile silicone or a volatile hydrocarbon. The anhydrous, topically-effective composition is useful in topical cosmetic and medicinal preparations, such as antiperspirants, sunscreens and topical drug products, and is especially useful in cosmetic and medicinal preparations wherein an insoluble topically-active compound is dispersed throughout a liquid phase.
Drugs covered by this patent
- Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.